Home › Drug Codes › Q Codes › Q5168 · Nufymco
Updated July 1st, 2026

Nufymco Q Code: Q5168

Injection, ranibizumab-leyk (nufymco), biosimilar, 0.1 mg

Login to unlock all benchmarks

Q4 2026 Medicare Payment Limit for Q5168, effective October 1, 2026: $26.384 per HCPCS billing unit. CMS publishes none for Q3 2026. From CMS's final file.

?
Medicare Payment Limit ?
Not published
CMS publishes none for Q3 2026
APC Payment Limit ?
Not published
CMS publishes none for Q3 2026
ASP ?
No current ASP
Not available for Q3 2026
WAC · AWP ?
$•••.••
Login to view
NDCs Crosswalked ?
2
View NDC crosswalk →

Drug & Product Overview

HCPCS Descriptor Injection, ranibizumab-leyk (nufymco), biosimilar, 0.1 mg
HCPCS Added Date July 1, 2026
Manufacturer Zydus Pharmaceuticals
Route of Administration Intravitreal
Generic Status Single-Source; Branded
Dosage Form Injection, Solution

About Nufymco

Nufymco is a medication aligned to the HCPCS Q Code: Q5168 for billing, pricing, and reimbursement purposes in the United States. This Ophthalmology medication is administered via the intravitreal route and manufactured by Zydus Pharmaceuticals.

Manufacturers, reach out to us to add more information.

NDC Code Information

Based on publicly available CMS files. Showing 1 of 2 NDCs — log in for the full crosswalk.

NDC Code Drug Manufacturer Billing Units / Pkg Package Size
70710-2173-01 Nufymco Zydus Pharmaceuticals USA Inc. 5 0.5 MG / 0.05 ML
•••••-••••-•• Log in to view Nufymco
Login to view 1 more NDC package View pricing, complete NDC-to-HCPCS alignments, and package details.
Login →

Ranibizumab Biosimilar Information:

Nufymco Approval Date: December 18, 2025

Product Name HCPCS Code Active Ingredient BLA Type
Lucentis J2778 Ranibizumab 351(a) Originator Product
Byooviz Q5124 Ranibizumab 351(k) Interchangeable
Cimerli Q5128 Ranibizumab 351(k) Interchangeable
Nufymco Q5168 Ranibizumab 351(k) Interchangeable
Ranluspec N/A Ranibizumab 351(k) Interchangeable

Nufymco CPT Administration Codes

The below list of CPT codes is intended for informational purposes only and may not be exhaustive. CPT® codes and descriptions are copyright American Medical Association (AMA). All rights reserved.

CPT Code Description
67028 Intravitreal injection of a pharmacologic agent (separate procedure) 67028
Not on the CMS JW / JZ list

This product is new and does not yet appear on the CMS list of HCPCS pertaining to single-dose containers. Wastage billing guide →

Nufymco Clinical Information

Indications and drug classification.

Treated Diseases & Conditions

This list of indications is not exhaustive and may be subject to errors. The information on BuyandBill.com is intended for informational purposes only and should not be used for medical advice.

Diabetic Macular Edema (DME) Diabetic Retinopathy (DR) Macular Edema Following Retinal Vein Occlusion (RVO) Myopic Choroidal Neovascularization (mCNV) Neovascular (Wet) Age-Related Macular Degeneration (AMD)
Drug Class
Vascular Endothelial Growth Factor Inhibitor [EPC]Vascular Endothelial Growth Factor Inhibitors [MoA]

Login for BuyandBill.com Analytics

Unlock deeper insights with BuyandBill’s Comparative Report!

  • Compare ASP, WAC, and AWP across drugs.
  • Visualize Drug Price Movement Over Time
  • Tailor reports to drug class, manufacturer, or HCPCS Code.
  • Compare Biosimilar and 505(b)(2) products.

Frequently Asked Questions

Is there an available Nufymco billing and coding guide?
A manufacturer-published billing and coding guide for NUFYMCO was not found.
Are there any available Nufymco patient assistance programs?
No manufacturer-published NUFYMCO patient assistance link was found.
Where can I find Nufymco prescribing information?
No NUFYMCO prescribing information link was found.
Where can I find Nufymco side effect information?
Information regarding NUFYMCO's side effects can be found at MedlinePlus Visit Here →
Does billing NUFYMCO require JZ/JW wastage modifiers?
This product is new and does not yet appear on the CMS list of HCPCS pertaining to single-dose containers.

About BuyandBill.com:

The BuyandBill.com team is dedicated to delivering high-quality coding and billing information for office-administered drugs. We continuously research HCPCS-coded medications to expand our resources and ensure data accuracy. Manufacturers: click here to sponsor your medication, and we will ensure the most accurate and detailed information is displayed.